Evidence map›Paper›PMID 35608807›Full record

ArticleMolecular diversity2023

Creation of targeted compound libraries based on 3D shape recognition.

Andrii Kyrylchuk, Iryna Kravets, Anton Cherednichenko, Valentyna Tararina, Anna Kapeliukha, Dmytro Dudenko, Mykola Protopopov

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andrii KyrylchukChemspace LLC, Kiev, Ukraine.ORCID http://orcid.org/0000-0002-8845-5194
Iryna KravetsChemspace LLC, Kiev, Ukraine.
Anton CherednichenkoChemspace LLC, Kiev, Ukraine.
Valentyna TararinaChemspace LLC, Kiev, Ukraine.
Anna KapeliukhaChemspace LLC, Kiev, Ukraine.
Dmytro DudenkoEnamine Ltd., Kiev, Ukraine.
Mykola ProtopopovChemspace LLC, Kiev, Ukraine. m.protopopov@chem-space.com.ORCID http://orcid.org/0000-0002-2716-4844

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the emerging field of drug discovery, rapid virtual screening methods become extremely valuable, especially when dealing with ultra-large databases of organic small bioactive molecules. In this work, we present a fast, computationally resource-efficient, and simple workflow for screening targeted compound libraries generated from ultra-large virtual chemical space. This workflow aims to find compounds with similar molecular 3D shapes with reference ones, and at the same time to expand chemical diversity and to identify new and potentially active scaffolds. This pipeline ensures the enrichment of the generated libraries with novel chemotypes. Also, it was shown that delicate tailoring of the physicochemical parameters of the search set ensures that all library compounds will possess desired property distributions. A visual inspection has shown that found structures bind to the receptor in the same way as the reference ones. Using our screening workflow, we have created a number of conventional protein-targeted libraries: the GPCRs Targeted Library (531 K compounds) and the Protein Kinases Targeted Library (113 K compounds). The described pipeline and scripts are freely accessible at: https://github.com/ChemSpace-LLC/usrcat_sim .

Indexed as

AlgorithmsDrug Discovery3D Shape recognitionComputer-aided drug discoveryLigand-based drug discoveryNovel chemotypesUSRCAT

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.